1) March 30: Anavex announces 3-71 is set up for FTD trial with enrollment beginning in Q2
2) March 31: Dr. M discloses 15 month data which presents that current group of 25 have all improved in MMSE et al scores over the 12 month data
3) April 3: PD/PK study results are disclosed
4) April 5: Anavex announces the commencement of Rett Syndrome trial
5) April 7: Biogen abandons hostile takeover attempt (no PR)
6) April 10: MJFF announces it has completed enrollment for 2-73 trial with May 1st as date of last enrollee’s dosage of 2-73
7) April 18: Dr. M exposes the ICEBERG! He present a video of 25 engaged Australian trial participants, filmed on March 21st when he visited Melbourne for an encounter with them and Dr. MacFarlane.
That's why it went up the last three days in a row---the Oppie presentation. I'm betting Oppenheimer will come out with a strong buy recommendation within two weeks. Between that the Vienna conference the shorts will be in trouble. We have based for over a month and it's time for another leg up. Watch and learn.